Taspoglutide

From WikiMD's Wellness Encyclopedia

Taspoglutide is a glucagon-like peptide-1 agonist (GLP-1 agonist) that was under development for the treatment of Type 2 diabetes. It was developed by Ipsen and Roche, but its development was discontinued in 2011 due to adverse side effects.

History[edit | edit source]

Taspoglutide was first developed by the French pharmaceutical company Ipsen. In 2006, Ipsen entered into a partnership with the Swiss pharmaceutical company Roche to further develop and commercialize the drug. However, in 2011, Roche discontinued the development of Taspoglutide due to adverse side effects observed in phase III clinical trials.

Mechanism of Action[edit | edit source]

As a GLP-1 agonist, Taspoglutide works by mimicking the effects of the natural hormone glucagon-like peptide-1. This hormone is released in response to food intake and works to lower blood glucose levels by stimulating insulin secretion and inhibiting glucagon secretion. By mimicking this hormone, Taspoglutide helps to regulate blood glucose levels in individuals with Type 2 diabetes.

Clinical Trials[edit | edit source]

Taspoglutide underwent several phases of clinical trials. In phase II trials, it was found to be effective in reducing blood glucose levels and promoting weight loss in individuals with Type 2 diabetes. However, in phase III trials, a significant number of participants experienced severe gastrointestinal side effects, leading to the discontinuation of the drug's development.

Side Effects[edit | edit source]

The most common side effects observed in clinical trials of Taspoglutide were gastrointestinal in nature. These included nausea, vomiting, and diarrhea. In some cases, these side effects were severe enough to lead to discontinuation of the drug.

See Also[edit | edit source]


WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD